| VP-0393 |
Lumoxiti™ (moxetumomab pasudotox-tdfk) (Intravenous) |
|
| VP-0398 |
Libtayo® (cemiplimab-rwlc) |
|
| VP-0423 |
Infugem™ (gemcitabine) |
|
| VP-0425 |
Asparlas® (calaspargase pegol-mknl) |
|
| VP-0426 |
Elzonris™ (tagraxofusp-erzs) (Intravenous) |
|
| VP-0449 |
Herceptin Hylecta™ (trastuzumab and hyaluronidase-oysk) (Subcutaneous) |
|
| VP-0482 |
Polivy™ (polatuzumab vedotin-piiq) (Intravenous) |
|
| VP-0503 |
Reblozyl® (luspatercept-aamt) (Subcutaneous) |
|
| VP-0521 |
Padcev™ (enfortumab vedotin-ejfv) (Intravenous) |
|
| VP-0522 |
Enhertu® (fam-trastuzumab deruxtecan-nxki) (Intravenous) |
|
| VP-0528 |
Sarclisa® (isatuximab-irfc) (Intravenous) |
|
| VP-0531 |
Jelmyto™ (mitomycin) (Intra-pyelocalyceal) |
|
| VP-0532 |
Trodelvy™ (sacituzumab govitecan-hziy) (Intravenous) |
|
| VP-0535 |
Darzalex Faspro™ (daratumumab and hyaluronidase-fihj) (Subcutaneous) |
|
| VP-0547 |
Evomela® (melphalan) |
|
| VP-0550 |
Zepzelca™ (lurbinectedin) (Intravenous) |
|
| VP-0553 |
Phesgo™ (pertuzumab, trastuzumab and hyaluronidase-zzxf) (Subcutaneous) |
|
| VP-0558 |
Tecartus™ (brexucabtagene autoleucel) (Intravenous) |
|
| VP-0559 |
Monjuvi™ (tafasitamab-cxix) (Intravenous) |
|
| VP-0581 |
Danyelza® (naxitamab-gqgk) (Intravenous) |
|
| VP-0583 |
Margenza™ (margetuximab-cmkb) (Intravenous) |
|
| VP-0590 |
Breyanzi® (lisocabtagene maraleucel) (Intravenous) |
|
| VP-0598 |
Abecma® (idecabtagene vicleucel) (Intravenous) |
|
| VP-0599 |
Jemperli® (dostarlimab-gxly) |
|
| VP-0600 |
Zynlonta™ (loncastuximab tesirine-lpyl) (Intravenous) |
|
| VP-0607 |
Rybrevant™ (amivantamab-vmjw) (Intravenous) |
|
| VP-0624 |
Tivdak™ (tisotumab vedotin-tftv) (Intravenous) |
|
| VP-0647 |
Fyarro™ (sirolimus albumin-bound) (Intravenous) |
|
| VP-0658 |
Kimmtrak® (tebentafusp-tebn) (Intravenous) |
|
| VP-0663 |
Carvykti™ (ciltacabtagene autoleucel) (Intravenous) |
|
| VP-0664 |
Opdualag™ (nivolumab/relatlimab-rmbw) (Intravenous) |
|
| VP-0679 |
Pedmark® (sodium thiosulfate) (Intravenous) |
|
| VP-0682 |
Tecvayli™ (teclistamab-cqyv) (Subcutaneous) |
|
| VP-0683 |
Imjudo® (tremelimumab-actl) (Intravenous) |
|
| VP-0686 |
Elahere™ (mirvetuximab soravtansine-gynx) (Intravenous) |
|
| VP-0691 |
Adstiladrin® (nadofaragene firadenovec-vncg) (Intravesical) |
|
| VP-0692 |
Lunsumio™ (mosunetuzumab-axgb) (Intravenous) |
|
| VP-0700 |
Zynyz™ (retifanlimab-dlwr) |
|
| VP-0707 |
Omisirge® (omidubicel-onlv) |
|
| VP-0710 |
Epkinly™ (epcoritamab-bysp) |
|
| VP-0711 |
Columvi™ (glofitamab-gxbm) |
|
| VP-0722 |
Talvey™ (talquetamab-tgvs) |
|
| VP-0724 |
Elrexfio™ (elranatamab-bcmm) |
|
| VP-0735 |
Loqtorzi™ (toripalimab-tpzi) |
|
| VP-0741 |
Ryzneuta® (efbemalenograstim alfa-vuxw) (Subcutaneous) |
|
| VP-0748 |
Amtagvi® (lifileucel) |
|
| VP-0750 |
Tevimbra™ (tislelizumab-jsgr) |
|
| VP-0753 |
Anktiva® (nogapendekin alfa inbakicept-pmln) |
|
| VP-0756 |
Imdelltra™ (tarlatamab-dlle) (Intravenous) |
|
| VP-0761 |
Rytelo® (imetelstat) |
|
| VP-0766 |
Lymphir™ (denileukin diftitox-cxdl) |
|
| VP-367 |
Elitek® (rasburicase) (Intravenous) |
|
| VP-676 |
Rolvedon™ (eflapegrastim-xnst) (Subcutaneous) |
|
